Nov 18, 2021 / 08:00AM GMT
Michael Jonathan Yee - Jefferies LLC, Research Division - Equity Analyst
Well, welcome to another great session here at the 2021 Jefferies Global London Virtual and In-person Health Care Conference. I am very honored to have with us here on our virtual fireside chat the CEO of Moderna, Stephane Bancel. Thank you. I appreciate your time here today. Certainly, a very busy and, I don't know, a bit chaotic time period mostly because there are so many things going on all over the world.
Questions and Answers:
Michael Jonathan Yee - Jefferies LLC, Research Division - Equity AnalystI would love to just take a step back, Stephane. And maybe just pause and reflect on sort of where you think we are here in the pandemic and the distribution of COVID vaccines for 2021, and how Moderna is evolving into the end of the year -- you just gave guidance, and how that evolves into 2022? This was some, a bit of, I guess, investor debate about what the guidance sort of tells. But I would love to give you an opportunity to sort of talk about that in 2021 and going to 2022. That